Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Cook

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Cancer Medicine|November 11, 2024
Is Centralisation of Cancer Services Associated With Under-Treatment of Patients With High-Risk Prostate Cancer?-A National Population-Based StudyLu Han, Emily Mayne, Joanna Dodkins, et al.
The Cochrane Database of Systematic Reviews|February 21, 2022
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancerNatalie Yl Ngoi, Nicholas Lx Syn, Robby M Goh, et al.
Plos One|May 3, 2011
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effectsJessica E Haberer, Adrian Cook, A Sarah Walker, et al.
British Journal of Clinical Pharmacology|March 19, 2016
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African childrenAndrzej Bienczak, Adrian Cook, Lubbe Wiesner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in EnglandJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
Cancer|March 25, 2017
Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trialDan P Stark, Adrian Cook, Julia M Brown, et al.
BJU International|February 18, 2026
Characteristics and outcomes of men presenting with complications of metastatic prostate cancerArjun Nathan, Matthew G Parry, Adrian Cook, et al.
The Pediatric Infectious Disease Journal|February 15, 2013
Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and ZimbabweVictor Musiime, Adrian Cook, Sabrina Bakeera-Kitaka, et al.
Frontiers in Immunology|January 11, 2020
The Safety and Immunogenicity of GTU<sup>®</sup>MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ARTG Haidari, Suzanne Day, M Wood, et al.
European Urology Oncology|June 28, 2020
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's "M1|RT Comparison"Adnan Ali, Alex P Hoyle, Christopher C Parker, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Cancer Medicine|November 11, 2024
Is Centralisation of Cancer Services Associated With Under-Treatment of Patients With High-Risk Prostate Cancer?-A National Population-Based StudyLu Han, Emily Mayne, Joanna Dodkins, et al.
The Cochrane Database of Systematic Reviews|February 21, 2022
Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancerNatalie Yl Ngoi, Nicholas Lx Syn, Robby M Goh, et al.
Plos One|May 3, 2011
Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effectsJessica E Haberer, Adrian Cook, A Sarah Walker, et al.
British Journal of Clinical Pharmacology|March 19, 2016
The impact of genetic polymorphisms on the pharmacokinetics of efavirenz in African childrenAndrzej Bienczak, Adrian Cook, Lubbe Wiesner, et al.
European Journal of Cancer (Oxford, England : 1990)|March 8, 2025
Are evidence-based guidelines translating into clinical practice? A national population-based study of the use of treatment intensification in metastatic hormone-sensitive prostate cancer (mHSPC) in EnglandJoanna Dodkins, Adrian Cook, Emily Mayne, et al.
Cancer|March 25, 2017
Quality of life with cediranib in relapsed ovarian cancer: The ICON6 phase 3 randomized clinical trialDan P Stark, Adrian Cook, Julia M Brown, et al.
BJU International|February 18, 2026
Characteristics and outcomes of men presenting with complications of metastatic prostate cancerArjun Nathan, Matthew G Parry, Adrian Cook, et al.
The Pediatric Infectious Disease Journal|February 15, 2013
Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and ZimbabweVictor Musiime, Adrian Cook, Sabrina Bakeera-Kitaka, et al.
Frontiers in Immunology|January 11, 2020
The Safety and Immunogenicity of GTU<sup>®</sup>MultiHIV DNA Vaccine Delivered by Transcutaneous and Intramuscular Injection With or Without Electroporation in HIV-1 Positive Subjects on Suppressive ARTG Haidari, Suzanne Day, M Wood, et al.
European Urology Oncology|June 28, 2020
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE's "M1|RT Comparison"Adnan Ali, Alex P Hoyle, Christopher C Parker, et al.
Pageof 6